Donald J Trump (R) Sells HCA Healthcare (HCA) Stock

Donald J Trump, the former U.S. President, sold shares of HCA Healthcare, Inc. (NYSE: HCA) valued between $15,001 and $50,000. The transaction was reported on July 1, 2026, but actually took place on May 22, 2026. This sale is part of periodic transaction reports under the STOCK Act.

Other Institutional Activity in HCA Healthcare

Several institutional investors have adjusted their positions in HCA Healthcare recently. BlackRock, Inc. increased its holdings by 782,179 shares, bringing its total to about 13.36 million shares valued at approximately $6.32 billion, marking a 6.2% increase. Vanguard Capital Management LLC opened a new position with 10.18 million shares worth around $4.82 billion. Sanders Capital, LLC reduced its stake by 1,507,023 shares, now holding 8.96 million shares valued at $4.24 billion, a 14.4% decrease. State Street Corp slightly trimmed its position by 27,093 shares to 7.54 million shares, valued at about $3.57 billion. Meanwhile, FMR LLC increased its stake by 567,650 shares, ending with 4.4 million shares worth roughly $2.08 billion, reflecting a 14.8% increase.

HCA Healthcare, Inc. Stock Down 8.7%

Shares of NYSE:HCA traded near $390.49 on Wednesday. HCA Healthcare has a market cap of approximately $86.5 billion, with a P/E ratio of 13.4 and a forward P/E of 11.8. The stock's 52-week range is between $330.00 and $556.52. Its 50-day moving average is $408.52, while the 200-day moving average is $459.86. The company has a current ratio of 0.83 and a quick ratio of 0.64, indicating its short-term liquidity.

Recent Earnings

In its latest earnings report, HCA Healthcare posted revenue of $76.4 billion, reflecting a 4.3% growth. The company reported an EPS of $29.05, with a net margin of 8.9%. Investors can expect the next earnings announcement on July 24, 2026.

Dividend

HCA Healthcare pays an annual dividend of $3.12 per share, yielding 0.8%. The company's dividend payout ratio stands at 10.13%, reflecting a conservative approach to shareholder returns.

Insider Buying and Selling at HCA Healthcare, Inc.

Recent insider transactions at HCA Healthcare include Mike Marks, EVP and CFO, who sold and bought 3,336 shares on May 7, 2026. Additionally, insiders William Frist, Hugh Johnston, Michael Michelson, and Wayne Joseph Riley each bought shares on April 28, 2026.

Analysts Set New Price Targets

Analysts have maintained their ratings on HCA Healthcare. On June 22, 2026, TD Cowen maintained a 'buy' rating with a price target of $431. Bernstein held a 'hold' rating with a target of $413 on June 4, 2026. The consensus among analysts is a 'buy' rating, with a mean target price of $500.29 based on 21 analyst opinions.

About HCA Healthcare

HCA Healthcare, Inc., headquartered in Nashville, Tennessee, operates healthcare facilities in the U.S. The company owns and manages hospitals, surgery centers, urgent care centers, and diagnostic facilities. Led by CEO Mr. Samuel N. Hazen, HCA employs around 230,000 people and provides a wide range of medical services.

Bottom Line

Donald J Trump's sale of HCA Healthcare shares is part of routine financial disclosures required for public officials. Investors watch these transactions for potential insights into market sentiment. However, it's important to note that 13F filings and STOCK Act reports are backward-looking and may not reflect current positions.